15q Duplication Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-20
Clinical Trial Update: A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY) [Phase 2]
Phase 2 open-label pilot study of soticlestat in Duplication 15q and CDKL5 deficiency disorder has completed with posted results.